Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in disease
about
Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathyMonomethyl fumarate promotes Nrf2-dependent neuroprotection in retinal ischemia-reperfusionDrug and gene delivery to the back of the eye: from bench to bedside.A hypoxia-responsive glial cell-specific gene therapy vector for targeting retinal neovascularization.Assembly PCR synthesis of optimally designed, compact, multi-responsive promoters suited to gene therapy application.Specific tools for targeting and expression in Müller glial cells.
P2860
Hypoxia-regulated retinal glial cell-specific promoter for potential gene therapy in disease
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Hypoxia-regulated retinal glia ...... ential gene therapy in disease
@en
type
label
Hypoxia-regulated retinal glia ...... ential gene therapy in disease
@en
prefLabel
Hypoxia-regulated retinal glia ...... ential gene therapy in disease
@en
P2093
P2860
P356
P1476
Hypoxia-regulated retinal glia ...... ential gene therapy in disease
@en
P2093
C Kathleen Dorey
Howard M Prentice
Janet C Blanks
Manas R Biswal
P2860
P304
P356
10.1167/IOVS.10-6835
P407
P577
2011-11-01T00:00:00Z